FDA Panel Recommends Approval of First Nasal Spray to Combat Severe Allergic Reactions

FRIDAY, May 12, 2023 -- Outside advisers for the U.S. Food and Drug Administration voted Thursday to recommend approval of Neffy, the first epinephrine nasal spray for severe allergic reactions.
Although most of the Pulmonary-Allergy Drugs Advisory...